Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Board Changes

14 Jan 2025 07:00

RNS Number : 1558T
C&C Group Plc
14 January 2025
Β 

This announcement contains inside information.

C&C Group plc

("C&C" or "the Group")

Board Changes

C&C Group plc, the vertically integrated premium branded drinks group and leading drinks distributor to the UK and Ireland hospitality sectors, announces the following Board changes:

John Gibney has informed the Board of his intention to step down as a Non-Executive Director of the Group, with effect from 13 January 2025. John has worked closely with Andrew Andrea, Chief Financial and Transformation Officer, to deliver substantial improvement in the Group's risk and internal control processes. As such, he now feels this is an appropriate time for him to step down and the new leadership team to continue this work.

John will be succeeded by Feargal O'Rourke, Non-Executive Director, as Chair of the Audit Committee. During a 37 year career with PwC, latterly serving as Managing Partner inΒ IrelandΒ until his retirement from the professional services firm in October 2023, Feargal advised Irish and international companies on a broad range of financial issues including investment, financing and business structuring. InΒ January 2024, he was appointed byΒ Ireland'sΒ Minister for Enterprise, Trade and Employment as Chair ofΒ IDA Ireland and is also Chair of theΒ Institute of International and European Affairs, the Irish based international think tank.

Β 

In addition, Mark Chilton, Company Secretary and Group General Counsel, has notified the Board that he will retire on 31 August 2025. Gillian Kyle, currently Deputy Company Secretary, will take on the role of Company Secretary with effect from the close of the 2025 AGM. A highly experienced company secretariat professional, Gillian joined C&C in 2023 from The Weir Group PLC where she was Deputy Company Secretary (2015-2023), having previously held a similar role at Aggreko plc from 2008-2015.

As previously announced, Ralph Findlay will return to the position of Non-Executive Chair as of 1 March 2025 following a short period of transition after Roger White joins the business as Chief Executive Officer on 20 January 2025. Ralph will also resume the role of Chair of the Nomination Committee at that time.

Ralph Findlay, Chair and CEO of C&C Group plc, commented:

"On behalf of the Company and the Board, I would like to thank John for his significant contribution to C&C during his tenure with the business. We wish John every success for the future and are delighted to welcome Feargal to the role of Audit Committee Chair.

"I would also like to thank Mark for his dedication and commitment to the business over the last six years with the Group. We wish him well in his retirement later this year and look forward to Gillian supporting the Board as Company Secretary."

This announcement has been made in accordance with the requirements of Listing Rule 6.4.6 and there is no further information to be disclosed under the requirements of Listing Rule 6.4.8.

14 January 2025

Β 

ENQUIRIES

C&C Group plc

Email: investor.relations@candcgroup.ie

Instinctif Partners T: +44 (0)20 7457 2020

Justine Warren/ Tim Pearson/ Amelia Thorn

Email: candccapmkts@instinctif.com

Β 

Irish Media

FTI Consulting

Jonathan Neilan / Paddy Berkery / Niamh O'Brien

Tel: +353 86 231 4135 / +353 86 602 5988 / +353 87 707 8379

Email: C&CGroup@fticonsulting.com

Β 

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

Β· C&C Group's portfolio of owned/exclusive brands include Bulmers, the leading Irish cider brand and Tennent's, the leading Scottish beer brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent's brands to over 40 countries worldwide.

Β· C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.

Β· C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent's and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

C&C Group plc is an Irish incorporated FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOABRGDBDUBDGUX
Date   Source Headline
16th Oct 202511:10 amRNSDirector/PDMR Shareholding
7th Oct 20252:44 pmRNSHolding(s) in Company
3rd Oct 202511:21 amRNSNotice of Results Date
1st Oct 202511:07 amRNSTotal Voting Rights
22nd Sep 20255:31 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSBoard Change
18th Sep 20257:00 amRNSFY2026 First-Half Trading Update
17th Sep 20255:08 pmRNSHolding(s) in Company
17th Sep 20253:43 pmRNSDirector/PDMR Shareholding
15th Sep 20255:35 pmRNSHolding(s) in Company
10th Sep 20253:27 pmRNSHolding(s) in Company
2nd Sep 20253:10 pmRNSHolding(s) in Company
1st Sep 202510:38 amRNSTotal Voting Rights
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20258:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 202510:06 amRNSHolding(s) in Company
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20255:07 pmRNSDirector/PDMR Shareholding
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20252:00 pmRNSHolding(s) in Company
15th Aug 20251:59 pmRNSHolding(s) in Company
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20255:29 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20253:49 pmRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20259:53 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.